Related Experiment Video
Updated: Sep 7, 2025
05:41
Non-invasive Assessment of Microvascular and Endothelial Function
Published on: January 29, 2013
16.3K
Cutaneous Markers of Cardiovascular Diseases
Cláudia Brazão1, Rita Pimenta2, Catarina Queirós1
1Serviço de Dermatovenereologia. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa. Portugal.
Acta Medica Portuguesa
|June 20, 2022
Summary
Recognizing skin signs in cardiovascular disease patients is crucial for early diagnosis and treatment. This review highlights key dermatologic indicators that can improve patient outcomes and prognosis.
Area of Science:
- Dermatology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular diseases (CVDs) represent a major global health burden.
- High morbidity and mortality rates underscore the need for improved diagnostic strategies.
- Dermatologic manifestations are often overlooked in CVD patients.
Purpose of the Study:
- To review significant dermatologic signs associated with cardiovascular disease.
- To emphasize the importance of early recognition of these signs.
- To highlight the potential for improved diagnosis and patient prognosis.
Main Methods:
- Narrative review of existing literature.
- Identification and synthesis of key dermatologic findings in CVD.
- Focus on clinical relevance and diagnostic implications.
Main Results:
- Several dermatologic conditions are linked to underlying cardiovascular pathology.
- Early identification of these skin signs can prompt cardiovascular investigation.
- Underestimation of these signs can delay critical diagnosis and treatment.
Conclusions:
- Dermatologic signs serve as valuable, often underestimated, indicators of cardiovascular disease.
- Timely recognition facilitates earlier diagnosis and intervention.
- Integrating dermatologic assessment into routine care may improve CVD patient outcomes.
Related Concept Videos
01:29Assessment of the Cardiovascular System II: Inspection
401
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
401
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
330
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
330
01:27Assessment of the Cardiovascular System III: Palpation
491
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
491
01:29Cardiovascular System Abnormal Findings I: Inspection and Palpation
513
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
513
01:25Endocarditis II: Clinical Features of Infective Endocarditis
24
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
24